AVEX is the Class A common stock of AEVEX Corp., a Solana Beach, California-based defense technology contractor focused on unmanned aerial systems (UAS) and intelligence, surveillance, and reconnaissance (ISR). The $26 central target reflects the average of nine current analyst price targets, not a single firm's call. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The range is unusually wide. At the high end, Needham reiterated a $45 target in August 2026, while Bank of America Securities ($34) and J.P. Morgan ($32) also sit well above the mean. Mid-range, Goldman Sachs ($31), Jefferies ($26), RBC Capital ($22), and Oppenheimer ($21) cluster around $20 to $31. At the low end, Piper Sandler and UBS both carry $13 targets, with Piper Sandler cutting its target from $20 while keeping a Neutral rating.
This spread reflects a real split in the analyst consensus. Bulls argue that expanding demand across launched effects, precision strike, and maritime autonomy supports continued growth and a re-rating from what Jefferies described as a 50% discount to peers. More cautious voices, such as Piper Sandler and UBS, point to limited revenue visibility. Independent trackers frame the picture slightly differently: S&P Global shows 11 analysts with an average near $25.80, while MarketBeat counts 14 brokerages averaging about $28.73, underscoring that the "consensus" figure depends on which targets are included.
AEVEX shares closed near $12.13 on November 11, 2026. Reaching $26 would require a move of roughly 114%, which qualifies as a very large move rather than a modest or incremental one. Importantly, the stock traded as high as $42.34 over the past year, so a $26 level is not uncharted territory; it sits well below the prior peak and below the stock's 50-day moving average of about $15.
The path depends heavily on execution. Revenue for the quarter ending June 30, 2026 reached $201.79 million, up about 99.5% year over year and well above the roughly $155 million analysts expected, but earnings per share (EPS) of $0.01 missed the $0.06 consensus. That combination of strong top-line growth and thin profitability explains much of the valuation debate and the stock's recent weakness.
Several verified factors support a higher stock forecast. The company raised its 2026 guidance twice, and management highlighted recent contract activity during meetings with analysts, which RBC Capital cited as evidence of a strong revenue outlook. The Jefferies initiation followed AEVEX's acquisition of BlackSea and emphasized re-rating potential relative to defense peers. Sector-wide demand for attritable, autonomous systems and precision-strike capabilities remains robust, and a majority of covering analysts rate the stock Buy or Outperform. Because the stock already traded above $30 within the past year, the $26 target does not require an unprecedented valuation.
The principal obstacles are equally real. The EPS miss, paired with limited revenue visibility, has weighed on sentiment, prompting RBC Capital to note that revenue visibility "will remain a headwind." Piper Sandler's target cut to $13 and its Neutral rating reflect skepticism that near-term fundamentals justify the higher targets. At a P/E (price-to-earnings) ratio around 36 and a market capitalization near $1.32 billion, the shares still embed meaningful growth expectations. Any guidance shortfall, contract timing slip, margin compression, or sector rotation away from defense could keep the stock far from $26, and the $13 targets show that some analysts expect little upside at all.
Technically, the picture is defined by wide ranges rather than tight consolidation. The 52-week range spans $9.64 to $42.34, and the shares sit in the lower portion of that band, below the 50-day moving average near $15. The $13-to-$15 zone is a meaningful support area that aligns with the most cautious analyst targets, while $26 to $31 represents a broad resistance region where several mid-range targets cluster. A sustained move above the $15 area would be a first step toward rebuilding the trend that previously carried the stock above $30. From what I see, monitoring these levels closely helps clarify the setup.
Analyst price targets typically reflect a research horizon of about 12 months, though individual firms rarely disclose identical periods, and the August-to-October targets here reflect slightly different snapshots in time. Investors should watch quarterly earnings and guidance, contract announcements and backlog, margin progression, analyst target revisions, and defense-budget and unmanned-systems demand trends. Any change in the two-raises narrative, or fresh commentary on revenue visibility, is likely to move the debate between the $13 and $45 ends of the range.
The $26 central target is an analyst-derived average spanning a wide $13-to-$45 range, and it implies roughly 114% upside from the November 2026 price near $12.13. Support comes from accelerating defense revenue, two guidance raises, and a broad base of Buy ratings, while the obstacles include an EPS miss, weak revenue visibility, and a stock trading well below its prior highs. The target is achievable in principle because the shares have already traded above that level within the past year, but the wide analyst disagreement shows there is no consensus on timing or magnitude. Investors should focus on execution, guidance, and margin trends rather than treating the $26 figure as a forecast or a guarantee.
In my view, one tool I find useful for this kind of analysis is Tickeron's AI Daily Buy/Sell Signals. It uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. For a volatile name like AVEX, these signals can help traders discover opportunities, monitor positions, and spot shifting trends more efficiently than manual screening alone. I often turn to it to complement fundamental research on names with wide analyst ranges.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The RSI Indicator for AVEX moved out of oversold territory on October 27, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 1 similar instances when the indicator left oversold territory. In 1 of the 1 cases the stock moved higher. This puts the odds of a move higher at 90%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 5 of 5 cases where AVEX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Moving Average Convergence Divergence (MACD) for AVEX just turned positive on November 10, 2026. Looking at past instances where AVEX's MACD turned positive, the stock continued to rise in 3 of 3 cases over the following month. The odds of a continued upward trend are 90%.
Following a +4.93% 3-day Advance, the price is estimated to grow further. Considering data from situations where AVEX advanced for three days, in 22 of 28 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
AVEX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on November 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AVEX as a result. In 8 of 8 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVEX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for AVEX entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 42 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-1.322) is normal, around the industry mean (5.050). P/E Ratio (17.394) is within average values for comparable stocks, (17.247). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.110). Dividend Yield (0.000) settles around the average of (0.055) among similar stocks. P/S Ratio (1.310) is also within normal values, averaging (18.367).
The Tickeron SMR rating for this company is 75 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 82 (best 1 - 100 worst), indicating slightly worse than average price growth. AVEX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AVEX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry AerospaceDefense